Riociguat and Dipyridamole

Desk tier: Avoid together

Mechanism: labeled contraindication (labeled contraindication)

“Concomitant administration of Adempas with specific PDE-5 inhibitors (such as sildenafil, tadalafil, or vardenafil) or nonspecific PDE-5 inhibitors (such as dipyridamole or theophylline) is contraindicated”

Adempas (riociguat), section 4.3 Phosphodiesterase Inhibitors. DailyMed label

Open this pair in the desk

All pairs for Riociguat · Dipyridamole

Educational reference only. Not FDA-cleared. The Prescribing Information governs.